Overcoming Steroid Resistance in Pediatric Acute Lymphoblastic Leukemia—The State-of-the-Art Knowledge and Future Prospects

Acute lymphoblastic leukemia (ALL) is the most common malignancy among children. Despite the enormous progress in ALL therapy, resulting in achieving a 5-year survival rate of up to 90%, the ambitious goal of reaching a 100% survival rate is still being pursued. A typical ALL treatment includes thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kośmider, Kamil, Karska, Katarzyna, Kozakiewicz, Agata, Lejman, Monika, Zawitkowska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999045/
https://www.ncbi.nlm.nih.gov/pubmed/35409154
http://dx.doi.org/10.3390/ijms23073795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999045/
https://www.ncbi.nlm.nih.gov/pubmed/35409154
http://dx.doi.org/10.3390/ijms23073795

Ejemplares similares